急性淋巴细胞白血病的现实世界 - Suppr

Suppr

超能文献

The real world of acute lymphoblastic leukemia.

作者信息

Litzow Mark R

机构信息

Division of Hematology Mayo Clinic Rochester, MN 55902 USA.

出版信息

Haematologica. 2025 Jan 1;110(1):20-21. doi: 10.3324/haematol.2024.286346.

DOI:10.3324/haematol.2024.286346

PMID:39234859

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11694121/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a554/11694121/e3d0c1ecde38/11020.fig1.jpg

相似文献

The real world of acute lymphoblastic leukemia.急性淋巴细胞白血病的现实世界

Haematologica. 2025 Jan 1;110(1):20-21. doi: 10.3324/haematol.2024.286346.

Comparison between qualitative and real-time polymerase chain reaction to evaluate minimal residual disease in children with acute lymphoblastic leukemia.定性聚合酶链反应与实时聚合酶链反应在评估急性淋巴细胞白血病患儿微小残留病中的比较。

Rev Bras Hematol Hemoter. 2015 Nov-Dec;37(6):373-80. doi: 10.1016/j.bjhh.2015.08.003. Epub 2015 Sep 14.

Real-world treatment patterns of novel drugs in relapsed or refractory acute lymphoblastic leukemia patients in Japan.日本复发或难治性急性淋巴细胞白血病患者新型药物的真实世界治疗模式。

Future Oncol. 2023 Jun;19(19):1343-1356. doi: 10.2217/fon-2022-1314. Epub 2023 May 22.

Immunological Subtypes of Acute Lymphoblastic Leukemia- Beyond Morphology: Experience from Kidwai State Cancer Institute, Bengaluru, India.急性淋巴细胞白血病的免疫亚型——超越形态学：来自印度班加罗尔基德瓦伊邦立癌症研究所的经验

J Assoc Physicians India. 2017 Jul;65(7):14-17.

Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).建立并评估一种快速一步法高灵敏度实时定量 PCR 系统，用于检测费城染色体阳性急性淋巴细胞白血病（Ph+ ALL）中的小 BCR-ABL（e1a2）。

Jpn J Clin Oncol. 2024 Feb 7;54(2):153-159. doi: 10.1093/jjco/hyad156.

Evaluating the expression level of Survivin gene in different groups of B-cell acute lymphoblastic leukemia patients of Iran.评估不同伊朗 B 细胞急性淋巴细胞白血病患者群体中 Survivin 基因的表达水平。

Mol Biol Rep. 2019 Jun;46(3):2679-2684. doi: 10.1007/s11033-019-04703-z. Epub 2019 Apr 30.

Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen.接受改良 CALGB 10102 方案治疗的急性淋巴细胞白血病成人患者的真实世界结局。

Ann Hematol. 2023 Apr;102(4):897-906. doi: 10.1007/s00277-023-05141-5. Epub 2023 Mar 1.

Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real-world setting: Results from the NEUF study.在真实环境中使用blinatumomab 治疗急性淋巴细胞白血病的儿科患者：来自 NEUF 研究的结果。

Pediatr Blood Cancer. 2022 Apr;69(4):e29562. doi: 10.1002/pbc.29562. Epub 2022 Jan 19.

Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan.日本商业用替沙格赛定治疗儿童、青少年和青年急性淋巴细胞白血病的真实世界结果

Transplant Cell Ther. 2025 Feb;31(2):86-96. doi: 10.1016/j.jtct.2024.11.016. Epub 2024 Nov 30.

Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.基于一致免疫表型标准治疗的混合表型急性白血病患儿的预后。

Haematologica. 2010 Jun;95(6):928-35. doi: 10.3324/haematol.2009.014506. Epub 2010 Feb 9.

本文引用的文献

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.421例费城染色体阴性成人急性淋巴细胞白血病患者在一项受GIMEMA LAL1913临床试验启发的强化治疗方案下的治疗结果：一项校园ALL研究

Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638.

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.Blinatumomab 治疗成人 MRD 阴性急性淋巴细胞白血病。

N Engl J Med. 2024 Jul 25;391(4):320-333. doi: 10.1056/NEJMoa2312948.

Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.依妥珠单抗奥滨尤妥珠单抗作为费城染色体阴性 B 前体细胞 ALL 大于 55 岁患者的诱导治疗。

J Clin Oncol. 2024 Jan 20;42(3):273-282. doi: 10.1200/JCO.23.00546. Epub 2023 Oct 26.

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.PEG aspargase 改良的成人急性淋巴细胞白血病风险导向方案：GIMEMA LAL1913 试验结果。

Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596.

Benefits of Participation in Clinical Trials: An Umbrella Review.参与临床试验的益处：伞式综述。

Int J Environ Res Public Health. 2022 Nov 21;19(22):15368. doi: 10.3390/ijerph192215368.

Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial.Hyper-CVAD 和序贯blinatumomab 治疗新诊断的费城染色体阴性 B 细胞急性淋巴细胞白血病：单臂、单中心、2 期临床试验。

Lancet Haematol. 2022 Dec;9(12):e878-e885. doi: 10.1016/S2352-3026(22)00285-X. Epub 2022 Oct 22.

Real-World Evidence - Where Are We Now?真实世界证据——我们目前处于什么阶段？

N Engl J Med. 2022 May 5;386(18):1680-1682. doi: 10.1056/NEJMp2200089. Epub 2022 Apr 30.

Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?真实世界证据（RWE）——是颠覆性创新还是医学证据生成的悄然演进？

F1000Res. 2018 Jan 25;7:111. doi: 10.12688/f1000research.13585.2. eCollection 2018.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验